AGL — Agilon Health Share Price
Last Trade - 00:00- $13.54bn
- $12.48bn
- $1.22bn
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 794.41 | 1,218.33 | 1,779.77 | 2,480.95 | 53.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
agilon health, inc. is a healthcare company. The Company is focused in developing healthcare by the primary care physician (PCP). The Company has created an agilon Platform, which is a Total Care Model for community-based physicians. The agilon platform is focused on community-based physician groups, senior patients within these practices and enabling physician partners to move to a subscription-like Total Care Model. The platform is delivered to anchor physician groups through a long-term partnership model to support the adoption and success of a Medicare-centric. The platform is supporting the Total Care Model with technology, people, process and capital. The agilon health network allows independent doctors to collaborate with other community physicians.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- June 30th, 2021
- Incorporated
- April 21st, 2017
- Public Since
- April 15th, 2021
- No. of Employees
- 548
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 390,882,560
- Address
- 1 World Trade Center, Suite 2000, Long Beach, 90831
- Web
- https://www.agilonhealth.com/
- Phone
- +1 5622563800
- Auditors
- Ernst & Young LLP
Latest News for AGL
Upcoming events for AGL
FAQ
As of Today at 19:58 UTC, shares in Agilon Health are trading at $34.65. This share price information is delayed by 15 minutes.
Shares in Agilon Health last closed at $34.65 and the price had moved by over the past 365 days. In terms of relative price strength the Agilon Health share price has matched the S&P500 Index by over the past year.
The overall consensus recommendation for Agilon Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Agilon Health does not currently pay a dividend.
Agilon Health does not currently pay a dividend.
Agilon Health does not currently pay a dividend.
To buy shares in Agilon Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $34.65, shares in Agilon Health had a market capitalisation of $13.54bn.
Here are the trading details for Agilon Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: AGL
Based on an overall assessment of its quality, value and momentum Agilon Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Agilon Health is $42.80. That is 23.52% above the last closing price of $34.65.
Analysts covering Agilon Health currently have a consensus Earnings Per Share (EPS) forecast of -$0.51 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Agilon Health. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $34.65, shares in Agilon Health were trading -2.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Agilon Health.
Agilon Health's management team is headed by:
- Ronald Williams -
- Steven Sell -
- Ravi Sachdev -
- Timothy Bensley -
- Chris Casler -
We do not have data on Agilon Health's shareholders